4D Molecular Therapeutics, Inc. (FDMT)
4D Molecular Therapeutics, Inc. (FDMT)
| Financial Ratios | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Return on Equity | -15.218 | 3.836 | -15.414 | -12.986 |
| Net Profit Margin | -2,256.646 | 22.796 | -63,195.556 | -364,386.667 |
| Debt to Asset Ratio | 11.906 | 10.772 | 12.972 | 11.137 |
| Cash Ratio | 167.008 | 136.958 | 130.851 | 222.508 |
| Quick Ratio | 933.932 | 939.261 | 841.828 | 874.606 |
| Current Ratio | 933.932 | 939.261 | 841.828 | 874.606 |